These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 380298)

  • 1. Chemical characterization of radiolabeled lymphocyte activation products of guinea pig associated with macrophage migration inhibitory activity (MIF).
    Klinkert W; Sorg C
    Adv Exp Med Biol; 1979; 114():469-74. PubMed ID: 380298
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of four lymphocyte activation products of guinea pig and their association with macrophage migration inhibitory activity (MIF).
    Klinkert W; Sorg C
    Mol Immunol; 1980 May; 17(5):555-64. PubMed ID: 7012583
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of an antibody against guinea pig MIF. II. Analysis of the antibody-reacting material using radiolabeled lymphokines.
    Onozaki K; Haga S; Miura K; Homma Y; Hashimoto T
    Cell Immunol; 1980 Oct; 55(2):465-75. PubMed ID: 7000379
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification of guinea pig pH 3 migration inhibitory factor.
    Remold HG; McCarthy PL; Mednis AD
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4088-91. PubMed ID: 7027252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration inhibitory factor.
    Remold HG; Mednis AD
    Methods Enzymol; 1985; 116():379-94. PubMed ID: 3911018
    [No Abstract]   [Full Text] [Related]  

  • 7. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemistry and in vitro activity of soluble factors of activated lymphocytes.
    Sorg C
    Mol Cell Biochem; 1979 Dec; 28(1-3):149-67. PubMed ID: 393992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two migration inhibitory factors with different chromatographic behavior and isoelectric points.
    Remold HG; Mednis AD
    J Immunol; 1977 Jun; 118(6):2015-9. PubMed ID: 325133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse spleen cell-derived toxoplasma growth inhibitory factor: its separation from macrophage migration inhibitory factor.
    Nagasawa H; Igarashi I; Matsumoto T; Sakurai H; Marbella C; Suzuki N
    Immunobiology; 1980 Dec; 157(4-5):307-19. PubMed ID: 7005083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface receptors for lymphokines. I. The possible role of glycolipids as receptors for macrophage migration inhibitory factor (MIF) and macrophage activation factor (MAF).
    Poste G; Kirsh R; Fidler IJ
    Cell Immunol; 1979 Apr; 44(1):71-88. PubMed ID: 378418
    [No Abstract]   [Full Text] [Related]  

  • 12. Products of activated lymphocytes. I. The use of radiolabeling techniques in the characterization and partial purification of the migration inhibition factor of the guinea pig.
    Sorg C; Bloom BR
    J Exp Med; 1973 Jan; 137(1):148-70. PubMed ID: 4688317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of an antibody against guinea pig MIF. I. Specificity of the anti-MIF antibody.
    Onozaki K; Haga S; Miura K; Ichikawa M; Hashimoto T
    Cell Immunol; 1979 Dec; 48(2):258-66. PubMed ID: 389441
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokines. II. Use of horse monocytes as indicator cells for human MIF.
    Friedrich W; Lazary S; de Weck AL
    Int Arch Allergy Appl Immunol; 1976; 50(2):142-54. PubMed ID: 1107231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial purification of guinea pig MIF by affinity column chromatography using macrophages.
    Onozaki K; Haga S; Miura K; Hashimoto T
    Microbiol Immunol; 1979; 23(6):533-41. PubMed ID: 114736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on guinea-pig macrophage migration inhibitory factor (MIF). I. Glycoprotein nature and net charge.
    Kotkes P; Pick E
    Clin Exp Immunol; 1979 Sep; 37(3):532-9. PubMed ID: 228883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of antisera against guinea pig macrophage activating factor.
    Peck R; Talmadge K; Polak L
    Int Arch Allergy Appl Immunol; 1984; 75(4):361-7. PubMed ID: 6389371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.